banner

Friday 5 June 2020

 

This Newsletter covers Federal and State policy and legislative developments in the area of health. Copies of documents referred to can be obtained by clicking on the reference in this Newsletter or through Capital Monitor's collection at www.capitalmonitor.com.au or from the source quoted.


Major Announcements


Coronavirus (COVID-19)

5 June

Remote travel restrictions lifted in Western Australia
Minister for Health Greg Hunt
and Minister for Indigenous Australians Ken Wyatt said the Western Australia will join the Northern Territory in lifting travel restrictions across remote communities. The Australian Government has taken this action in response to a request by the Minister for Health and Mental Health of Western Australia Roger Cook, to lift the restrictions currently in place through the Emergency Determination under the Biosecurity Act 2015. The decision to lift the Emergency Determination in Western Australia is based on expert advice from the Chief Medical Officer, Professor Brendan Murphy, and is in line with the Framework for Easing Remote Restrictions announced by the Prime Minister on 15 May 2020.
Download

4 June

COVID-19 and eligibility to request consent to supply therapeutic goods that do not comply with the new labelling requirements of TGO 92
The Department of Health and Therapeutic Goods Administration (TGA) said that the COVID-19 pandemic has placed unprecedented pressures and challenges on the pharmaceutical industry, including difficulty in implementing the new medicine labels that comply with the new labelling orders (TGO 91/92) for medicines that come into force on 1 September 2020. In recognition of these challenges, the Therapeutic Goods Administration (TGA) has established a temporary process for sponsors of listed, registered complementary, and over the counter (OTC) medicines to request consent to supply products that do not comply with TGO 92 due to adverse business impacts of COVID-19. The end date for this consent will be 6 March 2021.
Download

Risk of coronavirus contributes to growth in chemotherapy at home for Medibank customers
Medibank
's Chemotherapy at Home trial is experiencing increased demand from customers and oncologists. There was a 78% increase in Medibank customers receiving chemotherapy treatment at home between March and April, driven by the coronavirus (COVID-19) health emergency. The Medibank at Home chemotherapy trial gives eligible customers the choice to receive treatment in their own home, instead of hospital. For clinically suitable Medibank customers, this service is administered by an oncology nurse in the customer's own home at a time that's convenient. Medibank Chief Medical Officer Dr Linda Swan said more customers are now wanting to avoid hospital for their regular chemotherapy treatment.
Download

3 June

WA: COVID-19 update
The WA Department of Health has reported one new active case of COVID-19 overnight, bringing the State's total to 592. The new case is a male in his 30s who returned from overseas travel and is in hotel quarantine. There are currently 26 active cases in WA. Of the active cases, five are Western Australians, one is from interstate and twenty are crew members from the Al Kuwait. One confirmed COVID-19 case is in a Perth metropolitan hospital.
Download

2 June

$66 million for coronavirus-related research
The Government is investing $66 million into finding a vaccine and treatments for COVID-19, as well as better preparing for future pandemics, said Minister Hunt. This research will enable Australia's world-class researchers to contribute to global efforts to control and eliminate the virus. The funding is available through the Government's Medical Research Future Fund (MRFF), extending the $30 million already pledged for the Coronavirus Research Response. There is currently no vaccine or proven and effective treatments for COVID-19. The Government is absolutely committed to protecting the community and this will help ensure Australians are protected from COVID-19 at the earliest possible time.
Download

NSW: COVID-19 (Coronavirus) statistics
As at 8pm Monday 1 June 2020, there have been six new cases of COVID-19 diagnosed since 8pm 31 May, bringing the total number of cases in NSW to 3,104. All six new cases are travellers in hotel quarantine. There were 5,432 tests carried out in the reporting period, compared with 5,763 in the previous 24 hours. Nearly 510,000 COVID-19 tests have now been carried out in NSW. There are currently 72 COVID-19 cases being treated by NSW Health. This includes one person being treated in an intensive care unit, and that person does not require a ventilator. In NSW, 2,687 people have recovered from COVID-19, said NSW Health.
Download

QLD: Queensland novel coronavirus (COVID-19) update
Queensland has one new confirmed case of novel coronavirus (COVID-19) to report, said the Queensland Department of Health. The case is from the Gold Coast Hospital and Health Service. On 1 June, 2020, stage 2 of Queensland's Roadmap to Easing Restrictions came into effect. Changes include:
- Queenslanders can travel within Queensland, with no limit on distance except for discrete First nations communities restricted under the Biosecurity Act
- Queenslanders can stay overnight or longer at a place that is not your home. This easing of restrictions does not apply to biosecurity or restricted zones for indigenous communities.
Download

TAS: Dedicated COVID-19 testing for building and construction sites
'The Tasmanian State Government is the strongest supporter of the building and construction sector and this is why we have allowed it to stay operating during this challenging time with appropriate measures in place,' said Tasmanian Minister for Building and Construction Elise Archer. 'We remain committed to helping this essential sector address the significant impacts from COVID-19. We warmly welcome the new industry-backed initiative to support the health and safety of workers on construction sites across Tasmania. Workers at sites will now have dedicated asymptomatic COVID-19 mobile testing facilities under this new initiative being delivered by construction body Incolink and supported by industry.'
Download

WA: Western Australia expands asymptomatic COVID-19 testing
Following a successful start to the two-week DETECT Snapshot asymptomatic COVID-19 testing program, the WA State Government has announced a major expansion of work groups eligible for participation, said WA Minister for Health Roger Cook. From Wednesday June 3 until Wednesday June 10, the following workers who are aged over 18 years and display no symptoms of COVID-19 will be able to undergo a swab test for the virus:
- School staff involved in any function in a school setting (pre-kindergarten to Year 12), including Department of Education employees;
- Tourism sector staff of accredited tourism businesses;
- Transport workers such as truck, bus and train drivers.
Download

1 June

Working together to combat COVID-19 in the Pacific
The Australian Government is working in partnership with the Pacific Islands Forum to contribute to its initiative to establish a Pacific Humanitarian Pathway amid global supply chain disruptions. 'As a member of the Pacific Islands Forum, Australia is doing its part to operationalise the Pacific Humanitarian Pathway including through the implementation of protocols for freight and passengers that minimise the risk of COVID-19 transmission,' said Minister for Foreign Affairs Marise Payne. Minister for International Development and the Pacific Alex Hawke said Australia has worked with its Pacific family to combat COVID-19 since the beginning of the pandemic.
Download

QLD: COVID-19 - Tourism, travel boost / no new cases for four days
Tourism regions throughout the state will benefit from the Stage 2 easing of restrictions, with no new COVID-19 cases confirmed in Queensland for the fourth day in a row. There are five active cases, 1046 recovered and seven deaths for a total of 1058. Speaking in Cairns, Queensland Premier Annastacia Palaszczuk said tourism was being kick started because the health response had been so strong. 'I really want to thank Queenslanders for listening. Keep up the handwashing, keep up the social distancing and we will get through this together as we now can accelerate our economic recovery,' Ms Palaszczuk said.
Download

31 May

VIC: State of Emergency extended to keep slowing the spread
The State of Emergency in Victoria will be extended to slow the spread of coronavirus and keep people safe as restrictions are cautiously eased across the state. Victorian Minister for Health Jenny Mikakos announced the State of Emergency will be extended until 11.59pm on 21 June 2020. This extension will allow the Victorian State Government to continue to enforce strict physical distancing and isolation requirements, as well as other directions from the Chief Health Officer relating to businesses, working from home, mass gatherings and recreational activities.
Download

29 May

WA: Phase 3 of COVID-19 roadmap to commence from Saturday, June 6
The WA Government has announced Phase 3 of the roadmap to ease COVID-19 restrictions in WA, with significant changes coming into effect from Saturday, June 6. Phase 3 can be introduced from June 6 due to the success in limiting community transmission of COVID-19 in WA during Phase 2, and on the advice of the Chief Health Officer and State Emergency Coordinator, said WA Premier Mark McGowan. As per the advice from the Chief Health Officer, Western Australia's hard border with the rest of Australia will remain in place, said WA Minister for Health Roger Cook.
Download

Return to top


Aged Care

2 June

Medibank and St Vincent's Brisbane launch new at home palliative care service
St Vincent's Private Hospital Brisbane and Medibank have embarked on a new home-based palliative care pilot partnership, increasing the care and support options for patients with life limiting illnesses. The new pilot model is available for Medibank customers living in metropolitan Brisbane. Research by The Grattan Institute suggests there is an unmet need for at-home palliative care services - 70% of Australians would prefer the option of end of life care at home, however only about 14% do so. CEO of St Vincent's Private Hospital Brisbane Oli Steele said the model aimed to meet the needs of patients with progressive and advanced life-limiting illnesses by offering a range of support.
Download

1 June

Almost 60% of Australian aged care residents live in inadequately staffed facilities
More than half of all Australian aged care residents are in facilities that have inadequate staffing levels, and only 1.3% are in facilities with staffing levels considered to be best practice, according to the authors of a Perspective published online by the Medical Journal of Australia. Professor Kathy Eagar, Director of the Australian Health Services Research Institute at the University of Wollongong, and colleagues were tasked by the Royal Commission into Aged Care Quality and Safety to conduct a review of staffing levels in residential aged care facilities (RACFs).
Download

29 May

Register for aged care workers a step closer
The Government is a step closer to establishing a registration scheme for aged care workers, ensuring all staff are suitable to work with senior and vulnerable Australians. Minister for Aged Care and Senior Australians Richard Colbeck said a public consultation paper offered the opportunity to better regulate staffing across the sector. 'What we're looking for is a registration scheme that screens all aged care workers, without putting a red tape burden on them or service providers,' Minister Colbeck said. 'We also want to make sure that workers are still able to move between sectors, employers, regions and states as circumstances change.'
Download

Return to top


Royal Commission into Aged Care Quality and Safety

None this edition.

Return to top


Allied Health

None this edition.

Return to top


Children's Health

3 June

Community-led research that's improving the health of Aboriginal children
The Study of Environment on Aboriginal Resilience and Child Health (SEARCH) is Australia's largest ongoing study of the health of urban Aboriginal children and their families. Since 2008, SEARCH has been following over 1,600 Aboriginal children in urban and regional NSW to provide critical information about their ongoing health, from obesity and chronic disease, to hearing and speech development. SEARCH is the only platform of its kind, and is providing a holistic, ever-growing picture of the health and wellbeing of urban Aboriginal communities - evidence that is being used by communities to drive real improvements in health services.
Download

31 May

WA: Next step needed to protect children from tobacco harm
The WA Government is leading the charge across Australia in considering bold new measures to combat the way cigarettes are engineered. There are growing concerns that it is not only the ingredients in tobacco products that are highly dangerous, but also the way they are manipulated which makes the taste more appealing. This includes designing filters with special venting and 'squeeze' flavour capsules that can be crushed to release flavours that mask the chemical taste. WA Minister for Health Roger Cook is planning to raise his concerns with Commonwealth, State and Territory health ministers to investigate whether new laws were needed to control the composition and engineering of cigarettes.
Download

Return to top


Clinical Governance

3 June

ACT: Hospital visitor access restrictions eased
Visitor access restrictions at health services across the ACT were eased, allowing more people to visit Canberrans in hospital whilst remaining vigilant to the threat of COVID-19. From Thursday 4 June, new arrangements allowed patients to have up to two visitors per day. Only one visitor will be allowed with the patient at any one time to ensure physical distancing requirements are met. ACT Minister for Health Rachel Stephen-Smith acknowledged visitor restrictions have been difficult for patients, visitors and staff.
Download

31 May

Four times as many people trying to quit smoking during COVID-19
'On World No Tobacco Day, I encourage all smokers to call the Quitline and download the My Quitbuddy app to help them quit,' said Minister for Health Greg Hunt. 'Smokers who do so will be in good company - between January and May this year, the My Quitbuddy app was downloaded more than 24,000 times, a staggering 310 per cent increase over the same time last year. These figures are very encouraging and I congratulate those who have taken the first step. Quitting is not always easy, but assistance is available and the benefits are significant.'
Download

Return to top


Construction and Health Infrastructure

3 June

WA: Peel Health Campus upgrades to get under way
Upgrades to the emergency department at Peel Health Campus will recommence this month after being paused as part of the State's COVID-19 pandemic preparations, said WA Minister for Health Roger Cook. Construction work on the emergency department is part of a $10 million funding commitment for Peel Health Campus by the WA Government. Other improvements include an expanded car park, overhauled nurse call system and increased security. Residents in the Peel region will benefit from the upgraded emergency department, which will assist with patient flow, enhance patient confidentiality and privacy, and improve overall patient comfort and satisfaction.
Download

1 June

WA: State-of-the-art operating theatres open at Northam Health Campus
Northam Health Campus has officially opened two new fully integrated operating theatres featuring state-of-the-art technology as part of the WA Government's $42 million hospital redevelopment. The refurbishment is part of the biggest transformation of country hospitals and health services in more than a generation. Northam Health Campus has increased its operating theatre capacity from one to two theatres, as well as unveiled a refurbished recovery suite and a central sterile services department fitted with high-tech equipment, said Minister Cook.
Download

Return to top


Dental

None this edition.

Return to top


Disabilities

3 June

Delivering the NDIS: Annual Price Review Leads to Simpler, More Flexible Scheme
The Government has continued its delivery of the National Disability Insurance Scheme (NDIS) releasing the results of the 2020-21 NDIS Price Review. Minister for the National Disability Insurance Scheme Stuart Robert said the National Disability Insurance Agency (NDIA) is making improvements to NDIS pricing that better meets the needs of NDIS participants, their families, carers and providers across the NDIS market while maintaining the financial sustainability of the Scheme. The NDIS Price Guide and Support Catalogue is being released ahead of the new market settings becoming effective on 1 July.
Download

2 June

New CEO for Carers Australia
Liz Callaghan has been announced as the new CEO of Carers Australia. Ms Callaghan was a Director in the Aged Care Royal Commission Taskforce in the Department of Health's Ageing and Aged Care Group. Prior to joining the Department of Health, at the end of 2018, Ms Callaghan was CEO of Palliative Care Australia for four years where she advocated strongly for end of life issues to be recognised by governments, communities and the health and aged care sectors. Ms Callaghan has previously held roles in Catholic Health Australia, the South Australian and Victorian Departments of Health, Metropolitan Domiciliary Care, the Australian Council on Healthcare Standards and the Department of Management at RMIT University Melbourne.
Download

Return to top


Royal Commission into Violence, Abuse, Neglect and Exploitation of People with Disability

None this edition.

Return to top


E-Health

2 June

Australians increasingly online for health and wellbeing services
The Government welcomes new research showing that the health and wellbeing of Australians is increasingly supported by digital services. Conducted by Venture Insights on behalf of NBN Co, the research shows that while lifestyle habits have shifted dramatically as a result of the COVID-19 pandemic, the access Australians have to broadband has played a significant role connecting people to each other and to essential services. Minister for Communications, Cyber Safety and the Arts Paul Fletcher said the research demonstrates the critical role of the National Broadband Network (NBN) in boosting the nation's productivity, connectivity and social cohesion.
Download

Return to top


Education and Training

None this edition.

Return to top


Funding

5 June

$29 million to tackle nation's biggest killers
The Minister for Health Greg Hunt said that the Government is investing more than $29 million in vital research initiatives to tackle the nation's two biggest killers - heart disease and stroke. This funding is the first round of disbursements from the Government's 10 year, $220 million investment to boost research into heart disease and stroke through the Medical Research Future Fund's (MRFF) Cardiovascular Health Mission. Each year, one in five Australians are affected by heart disease and stroke, one Australian dies of cardiovascular disease every 12 minutes, and one Australian experiences a heart attack or stroke every five minutes.
Download

29 May

$2 million investment to extend Reclink National Program
The Government is investing $2 million to extend the Reclink National Program to deliver sport and recreation activities to people who may miss out on the health benefits of regular physical activity, said Minister Hunt. The Government encourages people across Australia to be physically active no matter what their circumstances or ability. Australians love their sport. The physical and mental health benefits of being active are well known. In the second half of 2019, Reclink delivered 55 sport and recreation programs across 25 locations, helping people achieve better health outcomes, build confidence and feel part of the community.
Download

Return to top


Health Professionals

4 June

RACGP calls for GPs to put on their crazy socks to tackle mental health stigma
The Royal Australian College of General Practitioners (RACGP) encouraged GPs to put on their 'crazy socks' to fight mental health stigma on Crazy Socks 4 Docs day on Friday 5th June. The RACGP has been a proud supporter of Crazy Socks 4 Docs day since it was started by Dr Geoffrey Toogood in 2017 to address mental health stigma among health practitioners. The RACGP has launched a new range of crazy socks to support the event this year. All of the proceeds will be donated to Beyond Blue, the mental health support service recommended by Dr Toogood. RACGP President Dr Harry Nespolon said the RACGP was proud to help raise awareness of the mental health of GPs around Australia.
Download

WA: Legionnaires' disease reminder for metropolitan Perth
Building managers are being reminded to maintain cooling towers and flush other water systems that may not have had regular use recently -- including showers, emergency eye baths, spas, fountains and ice machines -- to prevent Legionnaires' Disease. The warnings follow five cases of Legionnaires' Disease notified to the Western Australia Department of Health in metropolitan Perth. The Department recommends building managers seek advice from a water treatment provider to ensure correct maintenance of their cooling towers and water systems.
Download

2 June

VIC: Supporting brave nurses and midwives in hospitals
The Victorian Government is backing nurses and midwives with improved ratios that will see an extra 500 employed in Victorian hospitals and deliver better care to Victorians. 'Legislation will be introduced to enshrine further improvements to nurse and midwife to patient ratios ensuring nurses and midwives can devote more time to each patient - delivering better, safer care,' said Victorian Minister for Health Jenny Mikakos.
Download

Return to top


Hospitals

2 June

Medibank and St Vincent's Brisbane launch new at home palliative care service
St Vincent's Private Hospital Brisbane and Medibank have embarked on a new home-based palliative care pilot partnership, increasing the care and support options for patients with life limiting illnesses. The new pilot model is available for Medibank customers living in metropolitan Brisbane. Research by The Grattan Institute suggests there is an unmet need for at-home palliative care services - 70% of Australians would prefer the option of end of life care at home, however only about 14% do so. CEO of St Vincent's Private Hospital Brisbane Oli Steele said the model aimed to meet the needs of patients with progressive and advanced life-limiting illnesses by offering a range of support.
Download

30 May

TAS: Hospital visitation restrictions eased
From Monday, visits will now be able to occur between 2pm and 6pm, with a maximum of one visitor per patient at a time for most areas. To ensure staff and patient safety, visitors must complete the visitor screening tool on arrival, and importantly there will be assistance with these processes available for visitors who need it, said Minister for Health Sarah Courtney. Tasmanians must not visit a hospital, outpatient department or clinic if they have any symptoms. These include a fever, cough, sore throat, runny nose, gastrointestinal symptoms.
Download

29 May

Commonwealth and states sign $131 billion five year hospitals agreement
Public hospitals across the country will have record funding for the next five years after all states and territories signed onto the Government's new health reform agreement, said Prime Minister Scott Morrison. This record funding agreement will deliver more doctors, more nurses and more services across public hospitals in every state and territory, said Minister for Health Greg Hunt. This commitment ensures the Australian health system remains stable and nationally coordinated, particularly throughout this unprecedented time. Overall, the Commonwealth will invest an estimated $131.4 billion in demand driven public hospital funding to improve health outcomes for all Australians.
Download

New agreement brings fairness back to public hospitals
The new National Health Reform Agreement has the potential to end the practice of public hospitals 'harvesting' privately insured patients for their insurance benefits and ensure Australians who need care get it based on clinical need, not the ability to pay, said Australian Private Hospitals Association (APHA) CEO Michael Roff. The Agreement, signed by all States and Territories, includes a commitment to remove any financial benefit accruing to public hospitals for treating private patients. This means there will be no incentive for public hospitals to actively pursue privately insured Australians as they currently do.
Download

Return to top


Insurance

None this edition.

Return to top


Medicare

None this edition.

Return to top


Men's Health

None this edition.

Return to top


Mental Health

4 June

RACGP calls for GPs to put on their crazy socks to tackle mental health stigma
The Royal Australian College of General Practitioners (RACGP)
encouraged GPs to put on their 'crazy socks' to fight mental health stigma on Crazy Socks 4 Docs day on Friday 5th June. The RACGP has been a proud supporter of Crazy Socks 4 Docs day since it was started by Dr Geoffrey Toogood in 2017 to address mental health stigma among health practitioners. The RACGP has launched a new range of crazy socks to support the event this year. All of the proceeds will be donated to Beyond Blue, the mental health support service recommended by Dr Toogood. RACGP President Dr Harry Nespolon said the RACGP was proud to help raise awareness of the mental health of GPs around Australia.
Download

WA: Geraldton health and mental health facilities moving forward
Work is set to commence on the $73.3 million redevelopment of Geraldton Health Campus with ADCO Constructions Pty Ltd awarded the contract to deliver forward works. Western Australia Premier Mark McGowan and Minister for Health Roger Cook turned the sod to mark the start of construction of stage 1 of the redevelopment. The initial redevelopment phase includes an ambulance entry on Shenton Street, reconfiguration of the main entry to the hospital, and two new carparks. Ground works are expected to commence soon and be completed in the first quarter of 2021.
Download

1 June

More than $1 million in mental health support for younger veterans
Support for the mental health needs of younger veterans has received a boost with more than $1 million in grants or eight projects which will be delivered by ex-service organisations (ESOs) and other veteran community organisations. Minister for Veterans' Affairs Darren Chester said the latest round of the Supporting Younger Veterans grants has provided funding to projects that support the development of well-researched and tailored services and programs for younger veterans who may be at risk of experiencing poor mental health.
Download

SA: Multi million-dollar bushfire mental health and resilience package rolls-out
A new targeted mental health and wellbeing assistance is being rolled out to all residents of South Australia's bushfire-affected areas. SA Minister for Health and Wellbeing Stephen Wade said the $2.61 million package builds on the initial response to provide support for long-term recovery in the Adelaide Hills, Yorketown and Kangaroo Island communities which were severely impacted by the summer bushfires. The funding will support partnerships with NGOs and philanthropic organisations to provide programs and support.
Download

Return to top


Royal Commission into Victoria's Mental Health System

None this edition.

Return to top


Pharmaceuticals

4 June

Federal Court restrains MMS Australia from advertising and supplying MMS and DMSO
The Department of Health and Therapeutic Goods Administration (TGA) said that the Federal Court of Australia has made orders restraining Southern Cross Directories Pty Ltd trading as MMS Australia (MMS Australia) and its director Charles Barton from advertising and supplying goods containing certain potentially dangerous substances, including the main chemical used to make 'Miracle Mineral Solution' (MMS), until a further hearing. The Court adjourned the hearing to Wednesday, 10 June 2020, to allow Mr Barton and MMS Australia to obtain legal representation. The Court also made orders restraining MMS Australia and Mr Barton from advertising and supplying products containing sodium chlorite (the main chemical used to make MMS), DMSO or yohimbine until the hearing.
Download

COVID-19 and eligibility to request consent to supply therapeutic goods that do not comply with the new labelling requirements of TGO 92
The Department of Health and TGA said that the COVID-19 pandemic has placed unprecedented pressures and challenges on the pharmaceutical industry, including difficulty in implementing the new medicine labels that comply with the new labelling orders (TGO 91/92) for medicines that come into force on 1 September 2020. In recognition of these challenges, the Therapeutic Goods Administration (TGA) has established a temporary process for sponsors of listed, registered complementary, and over the counter (OTC) medicines to request consent to supply products that do not comply with TGO 92 due to adverse business impacts of COVID-19. The end date for this consent will be 6 March 2021.
Download

3 June

Critical medicines supply modelling supports return to elective surgery
New modelling demonstrates that current and anticipated supply of critical medicines for ventilating patients is sufficient to support both a return to elective surgery and a rise in COVID-19 cases. The modelling was undertaken as part of a coordinated effort to manage medicines supply during the COVID-19 pandemic by the TGA within the Department of Health, the pharmaceutical industry and medicines wholesaler groups, health professional bodies and state and territory health departments.
Download

COVID-19 test kits included in the ARTG for legal supply in Australia
The TGA has approved the following tests for inclusion in the Australian Register of Therapeutic Goods (ARTG). Conditions have been imposed on the supply of COVID-19 serology-based point of care tests. The Peter Doherty Institute for Infection and Immunity (the Doherty Institute) has been engaged by the Department of Health to assist with the post-market validation of new COVID-19 rapid tests to inform their best use.
Download

Clinical update: National Immunisation Program (NIP) schedule changes from 1 July 2020 - advice for vaccination providers
From 1 July 2020 there will be changes to the immunisation schedule designed to improve protection against meningococcal and pneumococcal disease. The changes are being implemented following recommendations from the Australian Technical Advisory Group on Immunisation (ATAGI) and other clinical experts. announced the Department of Health. The meningococcal B vaccine (Bexsero) will be added to the NIP for Aboriginal and Torres Strait Islander infants at 2, 4, and 12 months of age. Introduction of the vaccine will be supported by a catch-up program for all Aboriginal and Torres Strait Islander children aged under 2 years until 30 June 2023.
Download

Advisory Committee on Complementary Medicines (ACCM)
The Advisory Committee on Complementary Medicines (ACCM) was formed in January 2010 to advise and make recommendations to the TGA on the safety, efficacy and manufacturing quality of a complementary medicine in the Australian Register of Therapeutic Goods. The Committee is established under Regulation 39 of the Therapeutic Goods Regulations 1990 and the members are appointed by the Minister for Health, said the Department of Health. ACCM supersedes the Complementary Medicines Evaluation Committee (CMEC) and has an increased focus on the advisory role within the regulatory framework of complementary medicines.
Download

Advisory Committee on Chemicals Scheduling (ACCS)
The ACCS was established to advise and make recommendations to the Secretary of the Department of Health (or delegate) on the level of access required for chemicals and in some instances medicines Under revised scheduling arrangements, which took effect on 1 July 2010, the Secretary to the Department of Health (Health) superseded the National Drugs and Poisons Schedule Committee (NDPSC) as the decision maker for the scheduling of medicines and chemicals, said the TGA. Scheduling is a classification system that controls how medicines and chemicals are made accessible to consumers based on the substances contained within them.
Download

ACT: Canberra pharmacies stocked and ready for flu vaccinations
Additional supplies of influenza vaccines have arrived at ACT community pharmacies, prompting a call for people not yet vaccinated to take the opportunity to protect themselves against the flu. The Pharmacy Guild of Australia ACT Branch President, Simon Blacker, said demand for flu vaccination has been exceptionally high this year and largely unforeseen, partly because of the focus on health and respiratory wellness caused by the onset of the COVID19 crisis. Many community pharmacies across Australia used all of their pre-ordered stock and have been waiting for the new supplies commissioned by the Federal Government.
Download

2 June

Further changes to reduce opioid harm
The Department of Health through the TGA is continuing to implement a number of regulatory changes to reduce the harm caused by opioid prescription medicines to Australians. Every day in Australia, nearly 150 hospitalisations and 14 emergency department admissions involve issues relating to opioid use, and three people die from the harm that results. The majority of these admissions and deaths are from prescription opioids.
Download

Submissions received: Proposed clarification of the regulatory requirements for medical device systems or procedure packs
The TGA thanks respondents who provided submissions in response to the public consultation paper, 'Proposed clarification of the regulatory requirements for medical device systems or procedure packs'. The consultation was related to the implementation of the Australian Government Response to the Review of Medicines and Medical Devices Regulation (MMDR), in particular Recommendation 20, the regulation of medical devices in Australia, wherever possible, be aligned with the European Union (EU) framework. This consultation invited respondents to provide feedback on the proposed changes to the current regulatory requirements for medical device systems or procedure packs (SOPPs).
Download

Updates to the Prescribing Medicines in Pregnancy database
The TGA said that the Prescribing Medicines in Pregnancy database has been updated to include the following new entries:
- abemaciclib - pregnancy category D
- baloxavir - pregnancy category B3
- brigatinib - pregnancy category D
- brolucizumab - pregnancy category D
- caplacizumab - pregnancy category B1
- enasidenib - pregnancy category D
- glycopyrronium bromide - pregnancy category B3
- indacaterol/glycopyrronium - pregnancy category B3
- isavuconazole - pregnancy category D
- mecasermin - pregnancy category B3
- siponimod - pregnancy category D
- upadacitinib - pregnancy category D
- vandetanib - pregnancy category D.
Download

1 June

Expanded PBS medicines listings to provide new treatment options for over 170,000 asthmatics, and new hope for blood cancer patients
Australians with asthma and multiple myeloma will have broader access to life changing medicines as a result of expanded medicines listings on Pharmaceutical Benefits Scheme (PBS) from 1 June 2020, said Minister for Health Greg Hunt. The listing of Symbicort (containing budesonide and formoterol) will now be available at PBS prices for adolescent and adult patients with mild asthma. Symbicort will be available in two strengths of inhaler, Symbicort Turbuhaler 200/6, and Symbicort Rapihaler 100/3.
Download

29 May

Medicines misuse: Lessons from the coroner
A New South Wales coronial inquest into the deaths of three patients from prescription medicine misuse identified in each case actions that may have minimised the risk of harm to the patient, said the Pharmacy Guild of Australia. Guild Learning and Development has developed a new course titled Medicines misuse: Lessons from the coroner. The course uses the inquest as a basis to examine the role that pharmacists and other healthcare professionals play in reducing prescription medication-related deaths. It provides practical advice on interprofessional collaboration and partnering with patients to ensure the safe use of medicines such as opioids and benzodiazepines.
Download

Return to top


Research

5 June

$29 million to tackle Nation's biggest killers
The Minister for Health Greg Hunt said that the Government is investing more than $29 million in vital research initiatives to tackle the nation's two biggest killers - heart disease and stroke. This funding is the first round of disbursements from the Government's 10 year, $220 million investment to boost research into heart disease and stroke through the Medical Research Future Fund's (MRFF) Cardiovascular Health Mission. Each year, one in five Australians are affected by heart disease and stroke, one Australian dies of cardiovascular disease every 12 minutes, and one Australian experiences a heart attack or stroke every five minutes.
Download

4 June

Chief Medical Officer's statement on the National Dust Disease Taskforce
The Department of Health said that due to the COVID-19 pandemic the delivery of the final report of the National Dust Disease Taskforce will be extended until 30 June 2021. The Taskforce is committed to delivering high-quality advice for the development of a national approach to the prevention, early identification, control and management of occupational dust diseases in Australia. Consistent with the Taskforce's Terms of Reference, the final report will include consideration of ways to improve the system to ensure protection of at risk populations. The extension of time will allow the Taskforce to further consult with stakeholders to inform the development of a national strategy and address occupational dust disease issues.
Download

3 June

Federal support for Garvan COVID-19 research
Research at the Garvan Institute of Medical Research to develop an antiviral therapy for both COVID-19 protection and treatment has received a crucial boost by the Australian Government. The potential antibody therapy is particularly suited to at-risk individuals, including the elderly and chronically ill patients, and could be administered as a preventative therapy to health workers on the frontline. The grant, awarded through the Government's Medical Research Future Fund (MRFF), will support the Garvan Institute's research efforts to fight COVID-19 and was announced by the Health Minister Greg Hunt.
Download

2 June

$66 million for coronavirus-related research
The Government is investing $66 million into finding a vaccine and treatments for COVID-19, as well as better preparing for future pandemics. This research will enable Australia's world-class researchers to contribute to global efforts to control and eliminate the virus. The funding is available through the Government's Medical Research Future Fund (MRFF), extending the $30 million already pledged for the Coronavirus Research Response. There is currently no vaccine or proven and effective treatments for COVID-19, said Minister for Health Greg Hunt.
Download

Return to top


Rural, Regional and Remote Health

5 June

Remote travel restrictions lifted in Western Australia
Minister for Health Greg Hunt
and Minister for Indigenous Australians Ken Wyatt said the Western Australia will join the Northern Territory in lifting travel restrictions across remote communities. The Australian Government has taken this action in response to a request by the Minister for Health and Mental Health of Western Australia Roger Cook, to lift the restrictions currently in place through the Emergency Determination under the Biosecurity Act 2015. The decision to lift the Emergency Determination in Western Australia is based on expert advice from the Chief Medical Officer, Professor Brendan Murphy, and is in line with the Framework for Easing Remote Restrictions announced by the Prime Minister on 15 May 2020.
Download

4 June

New virtual hospital model to benefit rural patients and medical students
A new virtual health hospital that remotely tracks the condition of patients from their own home was unveiled in Armidale. Minister for Regional Health Mark Coulton received a demonstration of the New England Virtual Hospital's Joint Virtual Care Centre (JVCC). Minister Coulton said the new unique system continuously tracks heart rate, temperature, oxygen saturation and blood pressure through a band worn by patients and feeds the information back to doctors and nurses in the JVCC.
Download

TAS: Regional Health and Ambulance facilities to benefit from the Government's construction blitz
Tasmanian Minister for Health Sarah Courtney said that the Tasmanian Government has outlined details of our record two year construction blitz, to build our way out from the impacts of the COVID-19 pandemic. Importantly, $10 million will go towards upgrading regional health and ambulance facilities in Tasmania. These upgrades will provide better facilities for both staff and patients in our regional health facilities and improved facilities for paramedics at rural stations.
Download

Return to top


Women's Health

3 June

Time for SA Parliament to end harassment at the doors of abortion clinics
The safety and dignity of women seeking reproductive health services is a step closer to being protected in South Australia. The Health Care (Safe Access) Amendment Bill was introduced into South Australian Parliament by Nat Cook. The proposed laws would end the harassment of women at the doors of abortion clinics by creating safe access zones. Adrianne Walters, Acting Legal Director at the Human Rights Law Centre, welcomed the proposed law as a critical step to safeguarding South Australian women's health and equality.
Download

Return to top


Transcripts

Deputy Chief Medical Officer
04 JUN: Transcript of Interview by Deputy CMO, Professor Paul Kelly, with Sonya Feldhoff, ABC Radio Adelaide
Subjects: COVIDSafe app, Testing

Treasurer Josh Frydenberg
03 JUN: Transcript of Press Conference, Canberra
Subjects: National Accounts, COVID-19, GDP, Health related restrictions, Travel bans, Free Trade Agreements, National Medical Stockpile, RBA Governor, JobKeeper, OECD

Department of Health, Deputy Chief Medical Officer
03 JUN: Transcript of Deputy CMO, Paul Kelly's Press Conference
Subjects: Coronavirus (COVID-19), Health, Testing, Sports stadiums, Public gatherings, Social distancing, Trans-Tasman travel bubble

Minister for Health Greg Hunt
02 JUN: Transcript of Interview with Kieran Gilbert, Sky News
Subjects: COVID-19, Vaccine and treatment, Hydroxychloroquine, Potential outbreaks, Easing of restrictions, Queensland Health, World Health Organisation

Minister for Health Greg Hunt
02 JUN: Transcript of Doorstop Interview with Director of the Walter and Eliza Hall Institute of Medical Research, Doug Hilton, and Professor David Komander, Melbourne
Subjects: $66 million in COVID-19 research, Hydroxychloroquine

Minister for Trade, Tourism and Investment Simon Birmingham
02 JUN: Transcript of Interview with Jenna Clarke, The West Live
Subjects: Australian manufacturing, Barley tariffs, Australian farming, Relations with China, Tourism industry, Coronavirus, COVID-19, Airline industry

Shadow Treasurer Jim Chalmers
01 JUN: Transcript of Interview with Steve Austin, ABC Brisbane Drive
Subjects: Robodebt, National Cabinet, Health funding, Dental funding, State borders, Travel restrictions, Treasury, JobKeeper program, Government policy

Shadow Assistant Treasurer Stephen Jones
01 JUN: Transcript of Interview with Patricia Karvelas, ABC News Afternoon Live
Subjects: COVID-19, Gambling, Early access superannuation, Housing stimulus, JobKeeper and JobSeeker, US riots, ATO, Expenditure

Department of Health, Deputy Chief Medical Officer
31 MAY: Transcript of Deputy Chief Medical Officer, Nick Coatsworth's Doorstop Interview
Subjects: COVID-19, Public health measures, Tobacco, Anti-smoking initiatives

Prime Minister Scott Morrison, Chief Medical Officer
29 MAY: Transcript of Press Conference, Parliament House, Canberra ACT
Subjects: National Cabinet, COAG, COVID-19 response, Restrictions, Employment, Public health, Reserve Bank

Return to top


Reports

Australian National Disease Surveillance Plan for COVID-19 - Paper
Department of Health

The Australian National Disease Surveillance Plan for COVID-19 forms part of the Australian Health Sector Emergency Response Plan for Novel Coronavirus (COVID-2019). It is also a supporting plan to the Pandemic Health Intelligence Plan.1 The plan describes a national approach to disease surveillance for COVID-19, and the virus that causes it - severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). Surveillance is the ongoing, systematic collection, analysis and interpretation of health-related data. Data collected through the plan inform public health measures for control of COVID-19 in Australia. Australia is currently pursuing a suppression response strategy.
Download

Child wellbeing after parental separation
Australian Institute of Family Studies

This research summary highlights some key findings from a range of studies dealing with: the experiences of separated families; children's needs in the context of the family law system; and the impact of domestic and family violence on parenting.
Download

The Poisons Standard (the SUSMP)
Department of Health, Therapeutic Goods Administration (TGA)

The Poisons Standard is a Legislative Instrument for the purposes of the Legislative Instruments Act 2003. The Poisons Standard consists of decisions regarding the classification of medicines and poisons into Schedules for inclusion in the relevant legislation of the States and Territories. The Poisons Standard also includes model provisions about containers and labels, a list of products recommended to be exempt from these provisions, and recommendations about other controls on drugs and poisons.
Download

Australia's Mothers & Babies - 2018 in Brief - Report
Australian Institute of Health & Welfare (AIHW)

Australia's mothers and babies 2018-in brief presents an overview of the key statistics from the Australian Institute of Health and Welfare (AIHW) National Perinatal Data Collection. This report and the data visualisations are part of a comprehensive program of AIHW work on maternal and perinatal care and outcomes.
Download

Acute rheumatic fever & rheumatic heart disease in Australia, 2014-2018 - Report
Australian Institute of Health & Welfare (AIHW)

This report presents data from the National Rheumatic Heart Disease data collection, collated from the acute rheumatic fever (ARF) and rheumatic heart disease (RHD) registers in Queensland, Western Australia, South Australia and the Northern Territory. New South Wales register data are summarised also. The third version of the national guidelines for ARF and RHD management were released in February 2020. The 2nd version of the guidelines (released 2012) are relevant to the data in this report. ARF and RHD are preventable diseases affecting disadvantaged populations.
Download

Culturally and Linguistically Diverse (CALD) - Dementia Research Action Plan - Paper
National Health & Medical Research Council (NHMRC), National Ageing Research Institute (NARI)

The NHMRC National Institute for Dementia Research (NNIDR) 2019 Strategic Roadmap for Dementia Research and Translation provides a guide for research and translation aimed at improving the lives of people living with dementia, their families, and carers. This CALD Dementia Research Action Plan is founded on the Roadmap's principle of recognising and responding to Australia's cultural and linguistic diversity. This Action Plan has been developed and driven by NNIDR and the National Ageing Research Institute (NARI), and guided by a Steering Group comprising consumers, advocates, policy makers, and researchers.
Download

Principles of rapid innovation and evaluation, responding to COVID-19
Australian Research Alliance for Children & Youth (ARACY)

ARACY has produced these Principles in response to the way in which organisations of all kinds have rapidly modified their practice in the face of a global pandemic. As a hub of cross-sector activity and innovation, ARACY has seen many examples of creative changes to the way organisations deliver their work. These changes have ongoing value as we adapt to living with COVID-19. They know that changing social outcomes is a long game. Deep, rich knowledge acquisition takes decades, building on the work of those who have gone before them and laying the ground for those who will come after.
Download

Volume 212, No 10
Medical Journal of Australia (MJA)

Exponential epidemic growth has been clearly demonstrated for coronavirus disease 2019 (COVID- 19) in every country it has touched, with ascertained cases growing from 25 at the start of March in Australia to over 6000 cases 6 weeks later. For every ascertained case, there may be anywhere up to nine infections that are not detected. 1 This silent component of spread is likely driven by asymptomatic 2 or mild infection, especially in younger people. In countries which restrict testing to symptomatic high risk people only, there will be silent growth of undetected infection until the epidemic is large enough to be felt in the health system.
Download

Return to top


Hansards

Federal

29 MAY 2020: SENATE NOTICE PAPER: Questions on Notice - 1577 Senator Patrick: Minister for Health - Of total amount for pharmaceutical benefits, services & supply, how much is estimated to be payable to drug manufacturers

28 MAY 2020: SENATE COMMITTEE HANSARD: Senate Select Committee on COVID-19 - Australian Government's response to the COVID-19 pandemic - Canberra

NSW

02 JUN 2020: NSW ASSEMBLY HANSARD: Private Members' Statements - Inverell Hospital

02 JUN 2020: NSW COUNCIL HANSARD: Adjournment Debate - COVID-19 and Mental Health

02 JUN 2020: NSW COUNCIL HANSARD: Questions Without Notice - COVID-19 and Mental Health

02 JUN 2020: NSW COUNCIL HANSARD: Committees - Portfolio Committee No. 2 - Health - Reports

02 JUN 2020: NSW COUNCIL HANSARD: Deferred Answers - Toxic Shock Syndrome

02 JUN 2020: NSW COUNCIL HANSARD: Adjournment Debate - COVID-19 and Young People

South Australia

03 JUN 2020: SA COUNCIL HANSARD: Question Time - Country Health Services

02 JUN 2020: SA ASSEMBLY HANSARD: Answers to Questions - Local Health Networks

02 JUN 2020: SA ASSEMBLY HANSARD: Question Time - Disability Services

02 JUN 2020: SA ASSEMBLY HANSARD: Question Time - Integrity Care SA

02 JUN 2020: SA ASSEMBLY HANSARD: Answers to Questions - SA Pathology

02 JUN 2020: SA ASSEMBLY HANSARD: Answers to Questions - Coronavirus

02 JUN 2020: SA ASSEMBLY HANSARD: Question Time - National Disability Insurance Scheme

02 JUN 2020: SA ASSEMBLY HANSARD: Answers to Questions - Public Health Services

02 JUN 2020: SA COUNCIL HANSARD: Question Time - Disability Services

02 JUN 2020: SA COUNCIL HANSARD: Question Time - Coronavirus Restrictions

02 JUN 2020: SA COUNCIL HANSARD: Question Time - National Disability Insurance Scheme

Victoria

03 JUN 2020: VIC ASSEMBLY HANSARD: Questions Without Notice and Ministers Statements - COVID-19

03 JUN 2020: VIC COUNCIL HANSARD: Questions Without Notice and Ministers Statements - Latrobe Regional Hospital

03 JUN 2020: VIC ASSEMBLY HANSARD: Adjournment - Student Mental Health

03 JUN 2020: VIC ASSEMBLY HANSARD: Questions Without Notice and Ministers Statements - Ministers Statements: Royal Commission into Victoria's Mental Health System

03 JUN 2020: VIC ASSEMBLY HANSARD: Members Statements - COVID-19

03 JUN 2020: VIC ASSEMBLY HANSARD: Questions Without Notice and Ministers Statements - Ministers Statements: Mental Health Funding

03 JUN 2020: VIC ASSEMBLY HANSARD: Members Statements - Women's Health West

03 JUN 2020: VIC ASSEMBLY HANSARD: Bills - Safe Patient Care (Nurse to Patient and Midwife to Patient Ratios) Amendment Bill 2020 - Statement of Compatibility, Second Reading, Debate Adjourned

03 JUN 2020: VIC ASSEMBLY HANSARD: Members Statements - COVID-19 Vaccine Trials

03 JUN 2020: VIC ASSEMBLY HANSARD: Grievance Debate - COVID-19

03 JUN 2020: VIC COUNCIL HANSARD: Members Statements - COVID-19

03 JUN 2020: VIC COUNCIL HANSARD: Adjournment - Albury Wodonga Health

02 JUN 2020: VIC COUNCIL HANSARD: Announcements - COVID-19

02 JUN 2020: VIC COUNCIL HANSARD: Bills - Disability Service Safeguards Amendment Bill 2020 - Second reading, Committee, Third Reading

02 JUN 2020: VIC ASSEMBLY HANSARD: Members Statements - COVID-19

02 JUN 2020: VIC ASSEMBLY HANSARD: Bills - Safe Patient Care (Nurse to Patient and Midwife to Patient Ratios) Amendment Bill 2020 - Introduction and First Reading

Return to top


Court Cases

None this edition.

Return to top


New Regulations

Federal

Biosecurity Act 2015 - Subsection 477(1) - Biosecurity (Human Biosecurity Emergency) (Human Coronavirus with Pandemic Potential) (Emergency Requirements for Remote Communities) Amendment (No. 4) Determination 2020
Legislative Instrument- F2020L00668
The Amendment Instrument commences on 5 June 2020 and amends the Biosecurity (Human Biosecurity Emergency) (Human Coronavirus with Pandemic Potential) (Emergency Requirements for Remote Communities) Determination 2020. The amendment Instrument is automatically repealed after its commencement under section 48A of the Legislation Act 2003. The Determination remains in force in relation to the designated areas of Queensland and South Australia for the duration of the human biosecurity emergency period, unless it is revoked earlier.
Explanatory Statement

National Health (Immunisation Program - Designated Vaccines) Amendment Determination (No.2) 2020
Legislative Instrument - F2020L00669

The National Health (Immunisation Program - Designated Vaccines) Amendment Determination (No.2) 2020 (the Amendment Determination) amends the National Health (Immunisation Program - Designated Vaccines) Determination 2014 (No. 1) (the Determination) to add multicomponent meningococcal group B (4CMenB) to the list of designated vaccines.
Explanatory Statement

Therapeutic Goods (Permissible Ingredients) Determination (No. 2) 2020
Legislative Instrument - F2020L00666

Medicines that are listed in the Register under section 26A of the Act are considered to be low risk and are not individually evaluated before those medicines are listed. Medicines that are listed in the Register under section 26AE of the Act are also considered to be low risk, but are evaluated in relation to whether the efficacy of the medicine for the purposes for which it is to be used has been satisfactorily established (these purposes are specific efficacy claims for which the sponsor of the medicine holds supporting evidence). When listed under section 26AE, these listed medicines are commonly referred to as 'assessed listed medicines'.
Explanatory Statement

Financial Framework (Supplementary Powers) Amendment (Health Measures No. 3) Regulations 2020
Legislative Instrument - F2020L00659

The Regulations amend Schedule 1AB to the Principal Regulations to establish legislative authority for government spending on four initiatives that will be administered by the Department of Health. Funding will be provided for:
- the Perinatal Mental Health and Wellbeing Program for perinatal mental health support, perinatal loss and bereavement peer support, promotion and training activities (with funding of $43.9 million over seven years from 2018-19);
- the Perinatal Mental Health Check initiative to establish a national perinatal mental health check, including the delivery of digital perinatal screening infrastructure, training and support for perinatal mental health screening in public hospitals (with funding of up to $16 million over three years from 2020-21);
- the Donor Human Milk Bank Service to support the ongoing operation and expansion of a coordinated network of donor human milk banks (with funding of $2 million in 2019-20); and
- the establishment and operation of Adult Mental Health Centres to assist adults seeking help in times of crisis, or as needs emerge to have access to on-the-spot treatment, advice and support provided by a variety of health professionals (with funding of $93.5 million over four years from 2020-21).
Explanatory Statement

Aged Care (Leave from Residential Care Services) (Situation of Emergency
Legislative Instrument - F2020L00656

The purpose of the Aged Care (Leave from Residential Care Services) (Situation of Emergency-Human Coronavirus with Pandemic Potential) Determination 2020 (the Determination) is to declare the current COVID-19 pandemic as a situation of emergency for the purposes of subsection 42-2A(1) of the Act. Under the Determination, emergency leave will be available to aged care residents across Australia from 1 April 2020 to 30 September 2020.
Explanatory Statement

National Health (Pharmaceutical Benefits Scheme- Exempt items - Section 84AH) Amendment Determination 2020 (No. 1)
Legislative Instrument - F2020L00651

The purpose of this legislative instrument, made under section 84AH of the National Health Act 1953 (the Act), is to amend the legislative instrument titled National Health (Pharmaceutical Benefits Scheme-Exempt items - Section 84 AH) Determination 2017 (PB 81 of 2017) to make changes to the pharmaceutical items that are determined to be exempt items.
Explanatory Statement

National Health (Efficient Funding of Chemotherapy) Special Arrangement Amendment Instrument 2020 (No. 5)
Legislative Instrument - F2020L00649

The purpose of this Instrument, made under subsection 100(2) of the Act, is to amend the National Health (Efficient Funding of Chemotherapy) Special Arrangement 2011 (the Special Arrangement) to make changes relating to the Efficient Funding of Chemotherapy. The Special Arrangement achieves greater efficiency in payment for the supply of injected or infused chemotherapy medicines ('chemotherapy pharmaceutical benefits') to eligible patients being treated for cancer, to reflect the 2010 Budget measure titled 'Revised arrangements for the efficient funding of chemotherapy drugs'. The Special Arrangement also relates to the supply of medicines associated with the side-effects of cancer and cancer treatment ('related pharmaceutical benefits') at certain public hospitals.
Explanatory Statement

National Health (Price and Special Patient Contribution) Amendment Determination 2020 (No. 4)
Legislative Instrument - F2020L00648

This instrument (the Amending Determination) amends the Principal Determination by removing two brands of two pharmaceutical items that will no longer have a premium on 1 June 2020 in addition to removing two brands of two pharmaceutical items that will no longer be PBS listed on 1 June 2020.
Explanatory Statement

National Health (Prescriber bag supplies) Amendment Determination 2020 (No. 1)
Legislative Instrument - F2020L00647

The purpose of this legislative instrument, made under sections 93 and 93AB of the National Health Act 1953 (the Act), is to amend the National Health (Prescriber bag supplies) Determination 2012 (PB 73 of 2012) to make changes to the list of pharmaceutical benefits that may be supplied by medical practitioners and authorised nurse practitioners, respectively, directly to patients (prescriber bag supplies) and to the maximum quantity or number of units of these pharmaceutical benefits which may be obtained during a specified period by a medical practitioner and an authorised nurse practitioner.
Explanatory Statement

National Health (Highly specialised drugs program) Special Arrangement Amendment Instrument 2020 (No. 5)
Legislative Instrument - F2020L00646

This is the National Health (Highly specialised drugs program) Special Arrangement Amendment Instrument 2020 (No.5) (this Instrument). The purpose of this Instrument, made under subsection 100(2) of the Act, is to amend the National Health (Highly specialised drugs program) Special Arrangement 2010 (PB 116 of 2010) (the Special Arrangement), to make changes to the Special Arrangement relating to the Highly Specialised Drugs program. The amendments made by this Instrument reflect amendments to the National Health (Listing of Pharmaceutical Benefits) Instrument 2012 (PB 71 of 2012), which commence on the same day.
Explanatory Statement

National Health (Commonwealth Price and Conditions for Commonwealth Payments for Supply of Pharmaceutical Benefits) Amendment Determination 2020 (No. 3)
Legislative Instrument - F2020L00644

The purpose of this legislative instrument, made under section 98C(1) of the National Health Act 1953 (the Act), is to amend the National Health (Commonwealth Price and Conditions for Commonwealth Payments for Supply of Pharmaceutical Benefits) Determination 2019 (the Principal Determination) to make changes to the pharmaceutical benefits and ingredients in relation to which particular rules apply for ascertaining the Commonwealth price payable to an approved medical practitioner or an approved pharmacist for supply, and to make changes to the list of pharmaceutical benefits that must be supplied in complete packs.
Explanatory Statement

National Health (Continued Dispensing - Emergency Measures) Amendment Determination 2020 (No. 4) - PB 44 of 2020
Legislative Instrument - F2020L00643

The purpose of this legislative instrument, made under subsection 89A(3) of the National Health Act 1953 (the Act), is to amend the National Health (Continued Dispensing - Emergency Measures) Determination 2020 to make changes to the pharmaceutical benefits eligible to be provided as a Continued Dispensing supply. The National Health (Continued Dispensing - Emergency Measures) Determination 2020 (the Principal Instrument) expands the list of pharmaceutical benefits that can be supplied by an approved pharmacist under Part VII of the Act without a prescription, and provides the conditions for such a supply (a 'Continued Dispensing' supply).
Explanatory Statement

National Health (Listed drugs on F1 or F2) Amendment Determination 2020 (No. 5) - PB 48 of 2020
Legislative Instrument - F2020L00642

This Instrument (the Amending Determination) amends the Principal Determination by adding to F1 four new drugs; amino acid formula with carbohydrate without phenylalanine; amino acid formula with fat, carbohydrate without methionine; amino acid formula with fat, carbohydrate without phenylalanine and tyrosine; and amino acid formula with fat, carbohydrate without valine, leucine and isoleucine. It also moves one currently listed drug dutasteride with tamsulosin from the single brand administrative Combination Drug List (CDL) to F2. In addition, it also removes one drug from F1, oxytocin as this drug is no longer PBS listed.
Explanatory Statement

National Health (Listing of Pharmaceutical Benefits) Amendment Instrument 2020 (No. 5) - PB 42 of 2020
Legislative Instrument - F2020L00641

The purpose of this legislative instrument, made under sections 84AF, 84AK, 85, 85A, 88 and 101 of the National Health Act 1953 (the Act), is to amend the National Health (Listing of Pharmaceutical Benefits) Instrument 2012 (PB 71 of 2012) to make changes to the pharmaceutical benefits listed on the Pharmaceutical Benefits Scheme (PBS) and related matters. PB 71 of 2012 determines the pharmaceutical benefits that are on the PBS through declarations of drugs and medicinal preparations, and determinations of forms, manners of administration and brands.
Explanatory Statement

National Health (Originator Brand) Amendment Determination 2020 (No. 3) - PB 49 of 2020
Legislative Instrument - F2020L00640

This legislative instrument amends the National Health (Originator Brand) Determination 2015 (PB 100 of 2015) (the Principal Instrument) to determine the originator brand of a pharmaceutical item for one drug new to the Pharmaceutical Benefits Scheme (PBS) F2 formulary on 1 June 2020. The Principal Instrument determines originator brands of pharmaceutical items that have a drug on the F2 formulary. On meeting certain criteria, drugs move from the F1 formulary (see s 85AB of the Act), or the single brand Combination Drug List (CDL), to F2. All drugs on F2 are subject to price disclosure.
Explanatory Statement

Poisons Standard (No. 2) June 2020
Legislative Instrument - F2020L00639

The purpose of this instrument is to make a new Poisons Standard, the Poisons Standard (No.2) June 2020, in substitution for the previous Poisons Standard, the Poisons Standard June 2020, which was registered on 27 May and was to commence on 1 June 2020, and which is repealed and replaced by this new Poisons Standard. As the Poisons Standard June 2020 was to repeal the Poisons Standard February 2020, this new Poisons Standard also repeals the Poisons Standard February 2020.
Explanatory Statement

ACT

Public Health (Restricted Activities - Gatherings, Business or Undertakings) Emergency Direction 2020 (No 2)
Notifiable Instrument NI2020-317

The purpose of these directions is to restrict non-essential gatherings and the operation of non-essential businesses and undertakings in order to limit the spread of coronavirus disease 2019 (COVID-19), caused by the novel coronavirus SARS-CoV-2.
Download

Queensland

Health Legislation (COVID-19 Emergency Response) Regulation 2020
Subordinate Legislation 2020 No. 80

The policy objective of the Health Legislation (COVID-19 Emergency Response) Regulation 2020 (the regulation) is to extend statutory time limits relating to applications and reviews under the Food Act 2006 and Pest Management Act 2001. The regulation will facilitate effective administration and manage potential disruption for the food and pest control industries as a result of the COVID-19 emergency.
Explanatory Notes | Human Rights Certificate

Return to top


Proclamations

None this edition.

Return to top


Gazette Notices

Federal

03 JUN 2020: GOVERNMENT NOTICES GAZETTE: Therapeutic Goods Act 1989 - Section 38 - Publication of list of manufacturers granted licence for the manufacture of therapeutic goods

Return to top


Consolidated Legislation

Health Insurance (Section 3C Diagnostic Imaging Services-Multiparametric MRI of the prostate) Determination 2020
Legislative Instrument Compilation - F2020C00461

Determinations/Health as amended, taking into account amendments up to Health Insurance Legislation Amendment (Section 3C - Medical and Diagnostic Imaging Services) Determination 2020.
Administered by: Health
Download

Health Insurance (Section 3C General Medical Services - General Practitioner Telehealth Services) Determination 2018
Legislative Instrument Compilation - F2020C00460

Determinations/Health as amended, taking into account amendments up to Health Insurance (Section 3C General Medical Services - General Practice Telehealth Services for Bushfires Response) Amendment Determination 2020.
Administered by: Health
Download

Health Insurance (Section 3C General Medical Services - Additional GP Bulk-billing Incentives) Determination 2020
Legislative Instrument Compilation - F2020C00456

Determinations/Health as amended, taking into account amendments up to Health Insurance Legislation Amendment (Consequential Change to Incorporated GMST Clauses and Eye Movement Desensitisation and Reprocessing) Determination 2020.
Download

Return to top


New Bills

New South Wales

Mental Health and Cognitive Impairment Forensic Provisions Bill 2020 - LA Notice of Motion 2/6, LA intro, 1R, 2R 3/6

South Australia

Health Care (Safe Access) Amendment Bill 2020 - LA intro, 1R, 2R 3/6

Return to top


New Acts

None this edition.

Return to top


If you have any issues viewing this e-mail, please contact LexisNexis Capital Monitor on 02 6100 0801 or help@capmon.com

Subscribe | Unsubscribe | Privacy Statement | Contact Us | Twitter | Linkedin

© 2020 LexisNexis Capital Monitor

COPYRIGHT WARNING: This Newsletter is protected by copyright and may not be reproduced, copied or redistributed, in part or in whole, without the express permission of LexisNexis Capital Monitor.

WARNING - This email is confidential and may contain copyright material. If you are not the intended recipient of LexisNexis Capital Monitor original e-mail, please notify by return e-mail, delete your copy of the message, and accept our apologies for any inconvenience caused. Republication or re-dissemination, including posting to news groups or web pages, is strictly prohibited without the express prior consent of LexisNexis Capital Monitor.  2020 Reed International Books Australia Pty Ltd  (ABN 70 001 002 357) trading as LexisNexis. LexisNexis and the Knowledge Burst logo are registered trademarks of Reed Elsevier Properties Inc., and used under license.